NEW YORK, NY / ACCESS Newswire / April 13, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
You might also be interested in reading Bybit joins trend, releases Merkle Tree-verified proof of reserves.